Immunogenicity of the Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine Without Adjuvant in Healthy Adult Subjects
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 18 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 May 2010 Actual patient number (202) added as reported by ClinicalTrials.gov.
- 17 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.